Amarin Corp Plc (AMRN)

[everyonesguess]

Plausibly:

"While a blockbuster deal may not be imminent, Gilead is keeping its options open. Finance chief Robin Washington said on a call with analysts that planned repurchases could be paused if an acquisition opportunity comes up. And incoming CEO John Milligan said he plans to “work hard to help Gilead’s business grow beyond antivirals and into new therapeutic areas for the betterment of patients.”"